CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Apr. 30, 2016	Jul. 31, 2015
Current Assets:
Cash and cash equivalents	$ 47,171	$ 749,965
Other current assets	8,102	51,240
Total Current Assets	55,273	801,205
Property and Equipment, Net	1,753	2,869
Patents, Net	1,237,383	1,430,016
TOTAL ASSETS	1,294,409	2,234,090
Current Liabilities:
Accounts payable and accrued expenses (Note 4)	8,732,663	8,018,833
Total Current Liabilities	8,732,663	8,018,833
Derivative Warrant Liability (Note 7 and 8)	1,281,304	2,363,415
Derivative Additional Investment Rights Liability (Note 7 and 8)	158,893	142,662
Total Liabilities	10,172,860	10,524,410
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Common stock, $.001 par value; authorized 2,450,000,000 and 1,500,000,000 shares at April 30, 2016 and July 31, 2015, respectively; 903,333,142 and 825,496,238 issued and outstanding at April 30, 2016 and July 31, 2015, respectively	903,333	825,496
Additional paid-in capital	362,771,817	362,556,710
Accumulated deficit	(373,341,556)	(372,481,263)
Accumulated other comprehensive income	787,955	808,737
Total Stockholders' Deficiency	(8,878,451)	(8,290,320)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	1,294,409	2,234,090
Series A Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series B Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series C Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series D Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series E Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series F Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series G Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock